With well over 4,200 research, production, quality assurance, R&D, formulation scientists and support personnel, Cadila Pharmaceuticals Ltd., has one of the largest and most advanced pharmaceutical manufacturing and R&D facilities on the Asian Subcontinent. Additionally, Cadila has recently expanded and modernized its research and development facilities campus and now encompasses well over 45,000sq ft (4,180 m2) up to par with U.S., European and international standards. At 150+ strong, Cadila has one of the finest R&D scientific teams ever assembled. In recent years, Cadila has been granted several patents; from next generation antibiotics to advanced dermatological beta blockers us ing some of the latest techniques in biochemistry and molecular biology.